Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does childhood experience of attention-deficit hyperactivity disorder symptoms increase sleep/wake cycle disturbances as measured with actigraphy in adult patients with bipolar disorder?
Prunas C, Krane-Gartiser K, Nevoret C, Benard V, Benizri C, Brochard H, Faedda G, Geoffroy PA, Gross G, Katsahian S, Maruani J, Yeim S, Leboyer M, Bellivier F, Scott J, Etain B. Prunas C, et al. Among authors: gross g. Chronobiol Int. 2019 Aug;36(8):1124-1130. doi: 10.1080/07420528.2019.1619182. Epub 2019 Jun 6. Chronobiol Int. 2019. PMID: 31169034
Eveningness and poor sleep quality contribute to depressive residual symptoms and behavioral inhibition in patients with bipolar disorder.
Caruso D, Meyrel M, Krane-Gartiser K, Benard V, Benizri C, Brochard H, Geoffroy PA, Gross G, Maruani J, Prunas C, Yeim S, Palagini L, Dell'Osso L, Leboyer M, Bellivier F, Etain B. Caruso D, et al. Among authors: gross g. Chronobiol Int. 2020 Jan;37(1):101-110. doi: 10.1080/07420528.2019.1685533. Epub 2019 Nov 5. Chronobiol Int. 2020. PMID: 31690130
Clinical predictors of recurrences in bipolar disorders type 1 and 2: A FACE-BD longitudinal study.
Etain B, Bellivier F, Olié E, Aouizerate B, Aubin V, Belzeaux R, Courtet P, Dubertret C, Schwan R, Roux P, Polosan M, Leboyer M, Godin O; FondaMental Advanced Center of Expertise for Bipolar Disorders (FACE-BD); FACE-BD Clinical Sites and Principal Collaborators in France. Etain B, et al. J Psychiatr Res. 2021 Feb;134:129-137. doi: 10.1016/j.jpsychires.2020.12.041. Epub 2020 Dec 16. J Psychiatr Res. 2021. PMID: 33385631
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, Courtet P, D'Amato T, Dubertret C, Etain B, Haffen E, Januel D, Leboyer M, Lefrere A, Llorca PM, Marlinge E, Olié E, Polosan M, Schwan R, Walter M; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group; Passerieux C, Roux P. Vidal N, et al. Eur Neuropsychopharmacol. 2023 Dec;77:67-79. doi: 10.1016/j.euroneuro.2023.08.502. Epub 2023 Sep 21. Eur Neuropsychopharmacol. 2023. PMID: 37741163
Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders.
Chouchana M, Delage C, Godin O, Fontan JE, Bellivier F, Gard S, Aubin V, Belzeaux R, Dubertret C, Haffen E, Leboyer M, Olie E, Courtet P, Polosan M, Roux P, Samalin L, Schwan R, Lefrere A, Bloch V, Etain B; FondaMental Advanced Center of Expertise for Bipolar Disorders (FACE-BD). Chouchana M, et al. Eur Neuropsychopharmacol. 2023 Aug;73:75-81. doi: 10.1016/j.euroneuro.2023.04.005. Epub 2023 May 4. Eur Neuropsychopharmacol. 2023. PMID: 38465581
1,600 results